Afriag Global News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate announcements from Apollon Formularies, Final Results

AfriAg Global Plc - Notice of GM for Apollon Formularies Acquisition PR Newswire Proposed Appointments and Resignations General Meeting to Approve the Acquisition of Apollon Formularies Ltd Posting Admission Document and Notice of General Meeting Further to previous announcement regarding the proposed reverse take-over of medicinal cannabis company Apollon Formularies Ltd ("Apollon") (the "RTO" or the "Proposed Acquisition") on 23 February 2021, AfriAg is pleased to announce today the posting of its admission document and notice of general meeting to be held at 7-9 Swallow Street, London, Uni...

AfriAg Global Plc - Result of GM and AQSE Regulatory Approval for Apollon PR Newswire ("Company") AQUIS REGULATORY APPROVAL TO ACQUIRE APOLLON The Company is pleased to announce that at the General Meeting of the Company held today, all resolutions were duly passed. The Company is also pleased to announce that AQSE Regulatory approval to be admitted to the AQSE Growth Market has now been received to acquire the entire issued share capital of Apollon Formularies Limited, and it is expected that admission to trading will commence tomorrow, 13 April 2021 at 8 a.m. The Enlarged Share Capital of 7...

AfriAg Global Plc - Posting of Supplementary Admission Document PR Newswire Posting of Supplementary Admission Document The Company announces, further to the announcement of 19 March 2021, a supplementary admission document is being posted to shareholders today. Pursuant to Apollon's option to acquire 90% of the stock of Doc's Place under a Right to Purchase Understanding ("Doc's Place RPU"), and Apollon's exclusive right to purchase the assets and assume certain liabilities and obligations of CBev under a Right to Purchase Understanding ("CBev RPU"), an additional risk factor is being brough...

PROPOSED REVERSE TAKEOVER AND RE-ADMISSION TO AQSE AND £2.5 MILLION EQUITY RAISE. The Company expects that Admission post approval by regulators and...